Amylyx Pharmaceuticals, Inc.
AMLX
36 insider filings · Latest: Oct 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 9:00 PM | Gina MazzarielloChief Legal Officer | Sale | 6,844 | $14.52 | $99.4K | 134,430(D) | View → |
| Mar 2, 2026 | Mar 2 9:30 PM | Bedrosian Camille L | Proposed Sale | 6,461 | $14.58 | $94.2K | — | View → |
| Mar 2, 2026 | Mar 2 9:30 PM | Frates James M | Proposed Sale | 7,909 | $14.52 | $114.9K | — | View → |
| Mar 2, 2026 | Mar 2 9:30 PM | Klee Justin B. | Proposed Sale | 29,282 | $14.47 | $423.8K | — | View → |
| Mar 2, 2026 | Mar 2 9:30 PM | Mazzariello Gina | Proposed Sale | 6,844 | $14.52 | $99.4K | — | View → |
| Mar 2, 2026 | Mar 2 9:30 PM | Cohen Joshua B | Proposed Sale | 29,282 | $14.48 | $424.1K | — | View → |
| Feb 23, 2026 | Feb 25 9:00 PM | Gina MazzarielloChief Legal Officer | Sale | 3,419 | $14.14 | $48.4K | 141,274(D) | View → |
| Feb 23, 2026 | Feb 23 9:25 PM | Mazzariello Gina | Proposed Sale | 3,419 | $14.14 | $48.4K | — | View → |
| Feb 2, 2026 | Feb 4 9:05 PM | James M FratesChief Financial Officer | Sale | 3,557 | $14.65 | $52.1K | 173,547(D) | View → |
| Feb 2, 2026 | Feb 4 9:05 PM | Joshua B CohenDirector, Co-Chief Executive Officer | Sale | 15,500 | $14.68 | $227.6K | 3,363,965(D) | View → |
| Feb 2, 2026 | Feb 4 9:05 PM | Gina MazzarielloChief Legal Officer | Sale | 3,448 | $14.65 | $50.5K | 144,693(D) | View → |
| Feb 2, 2026 | Feb 4 9:05 PM | Justin B. KleeDirector, Co-Chief Executive Officer | Sale | 15,500 | $14.69 | $227.6K | 3,363,898(D) | View → |
| Feb 2, 2026 | Feb 2 9:10 PM | Mazzariello Gina | Proposed Sale | 3,448 | $14.65 | $50.5K | — | View → |
| Feb 2, 2026 | Feb 2 9:10 PM | Cohen Joshua B | Proposed Sale | 15,500 | $14.68 | $227.6K | — | View → |
| Feb 2, 2026 | Feb 2 9:10 PM | Klee Justin B. | Proposed Sale | 15,500 | $14.68 | $227.6K | — | View → |
| Feb 2, 2026 | Feb 2 9:10 PM | Frates James M | Proposed Sale | 3,557 | $14.65 | $52.1K | — | View → |
| Jan 16, 2026 | Jan 21 2:46 AM | Joshua B CohenDirector, Co-Chief Executive Officer | Sale | 1,974 | $13.83 | $27.3K | 3,379,465(D) | View → |
| Jan 15, 2026 | Jan 21 2:46 AM | Joshua B CohenDirector, Co-Chief Executive Officer | Sale | 136,193 | $13.59 | $1.9M | 3,378,621(D) | View → |
| Jan 16, 2026 | Jan 21 2:46 AM | Justin B. KleeDirector, Co-Chief Executive Officer | Sale | 1,995 | $13.89 | $27.7K | 3,379,398(D) | View → |
| Jan 15, 2026 | Jan 21 2:46 AM | Justin B. KleeDirector, Co-Chief Executive Officer | Sale | 136,193 | $13.58 | $1.8M | 3,378,546(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Sep 2 8:00 PM | Karen FirestoneDirector | Option Exercise | 50,000 | $5.05 | 0(D) | View → |
| Jun 4, 2026 | Jun 8 8:00 PM | Bernhardt G ZeiherDirector | Grant/Award | 24,372 | $14.31 | 24,372(D) | View → |
| Jun 4, 2026 | Jun 8 8:00 PM | Karen FirestoneDirector | Grant/Award | 24,372 | $14.31 | 24,372(D) | View → |
| Jun 4, 2026 | Jun 8 8:00 PM | Daphne QuimiDirector | Grant/Award | 24,372 | $14.31 | 24,372(D) | View → |
| Jun 4, 2026 | Jun 8 8:00 PM | George M Milne JRDirector | Grant/Award | 24,372 | $14.31 | 24,372(D) | View → |
| Jun 4, 2026 | Jun 8 8:00 PM | Paul R. FonteyneDirector | Grant/Award | 24,372 | $14.31 | 24,372(D) | View → |
| Mar 5, 2026 | Mar 9 8:00 PM | Joshua B CohenDirector, Co-Chief Executive Officer | Grant/Award | 373,295 | $14.10 | 373,295(D) | View → |
| Mar 5, 2026 | Mar 9 8:00 PM | Gina MazzarielloChief Legal Officer | Grant/Award | 111,990 | $14.10 | 111,990(D) | View → |
| Mar 5, 2026 | Mar 9 8:00 PM | James M FratesChief Financial Officer | Grant/Award | 143,985 | $14.10 | 143,985(D) | View → |
| Mar 5, 2026 | Mar 9 8:00 PM | Justin B. KleeDirector, Co-Chief Executive Officer | Grant/Award | 373,295 | $14.10 | 373,295(D) | View → |
| Mar 5, 2026 | Mar 9 8:00 PM | Camille L BedrosianChief Medical Officer | Grant/Award | 143,985 | $14.10 | 143,985(D) | View → |
| Jan 16, 2026 | Jan 21 2:46 AM | Joshua B CohenDirector, Co-Chief Executive Officer | Option Exercise | 2,818 | $7.57 | 0(D) | View → |
| Jan 15, 2026 | Jan 21 2:46 AM | Joshua B CohenDirector, Co-Chief Executive Officer | Option Exercise | 197,182 | $7.57 | 2,818(D) | View → |
| Jan 16, 2026 | Jan 21 2:46 AM | Justin B. KleeDirector, Co-Chief Executive Officer | Option Exercise | 2,847 | $7.57 | 0(D) | View → |
| Jan 15, 2026 | Jan 21 2:46 AM | Justin B. KleeDirector, Co-Chief Executive Officer | Option Exercise | 197,153 | $7.57 | 2,847(D) | View → |